Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Phase 2 Study of ET-743 (Trabectedin) in Patients With Persistent or Recurrent Endometrial Carcinoma

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. · 2002
ClinicalTrials.gov · Datasets · License: Public Domain · 2002
Open Source ↗
antineoplastic-agentscancercarcinoma
endometrial neoplasms, uterine neoplasms, genital neoplasms, female urogenital neoplasms, endometrial, cancer, carcinoma, trabectedin, ecteinascidin 743, et743, antineoplastic agents, alkylating agents, molecular mechanisms of pharmacological action
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 863088
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.